3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Synovitis: new trials by email Literature Review of Synovitis trials Research Report on Synovitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics) Tolbutamide, Midazolam, Pexidartinib - Drug Interaction Potential | Phase 1 | Completed | Daiichi Sankyo | 32 | 2018-02-26 | 2021-05-14 |
| Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor FPA008 - Pigmented Villonodular Synovitis, Tenosynovial Giant Cell Tumor | Phase 1 / Phase 2 | Completed | Five Prime Therapeutics, Inc. | 66 | 2015-06-01 | 2021-08-31 |
| Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis Patients 15-O labeled water - Rheumatoid Arthritis | Phase 1 | Completed | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 10 | 2001-04-01 | 2008-03-04 |
Synovitis, Pigmented Villonodular (2) · Arthritis (1) · Arthritis, Rheumatoid (1) · Giant Cell Tumor of Tendon Sheath (1)
Joint Diseases (3) · Musculoskeletal Diseases (3) · Giant Cell Tumors (2) · Muscular Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Tendinopathy (2) · Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Giant Cell Tumor of Tendon Sheath (1) · Immune System Diseases (1) · Rheumatic Diseases (1)
Bro protein, Drosophila (1) · Midazolam (1) · Tolbutamide (1) · cabiralizumab (1) · pexidartinib (1)
Daiichi Sankyo (1) · Five Prime Therapeutics, Inc. (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)
United States (3) · Netherlands (2) · France (1) · New Zealand (1) · Poland (1) · South Korea (1) · Taiwan (1) · United Kingdom (1)